{"id":263793,"date":"2026-09-23T11:31:15","date_gmt":"2026-09-23T06:01:15","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=263793"},"modified":"2026-09-23T11:31:15","modified_gmt":"2026-09-23T06:01:15","slug":"krishna-institute-of-medical-sciences-stock-signals-investors-are-watching","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/krishna-institute-of-medical-sciences-stock-signals-investors-are-watching\/","title":{"rendered":"Krishna Institute of Medical Sciences: 7 Stock Signals Investors Are Watching Right Now"},"content":{"rendered":"

Krishna Institute of Medical Sciences CMP Rs 796.10. 52W range Rs 575.80-858.00. Mcap Rs 33,199 crore. PE 170.72 vs sector 68.95.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

KIMS stock signals right now span an earnings picture, a shareholding pattern where promoter holding promoter and institutional shareholding figures were not available from the data source used here; investors can check the company’s latest exchange filing directly, and a technical setup where the stock trades well off its 52-week low of Rs 575.80. Debt to equity stands at 1.89, and valuation sits at a P\/E of 170.72 against a sector average of 68.95. Corporate developments in the multispecialty hospital and healthcare services space add further context investors are tracking alongside these numbers. None of the seven signals here amounts to a buy or sell call on its own.<\/p>\n<\/p><\/div>\n

KIMS stock signals are unusually layered right now, with the company trading at Rs 796.10, 7.2% below its 52-week high of Rs 858.00 and 38.3% above its 52-week low of Rs 575.80. Krishna Institute of Medical Sciences is a well tracked name in the multispecialty hospital and healthcare services space, and no single headline captures where the stock stands today.<\/p>\n

This article does not make a buy, hold or sell call on Krishna Institute of Medical Sciences. It lays out seven signals investors commonly watch, each sourced from the company’s latest exchange disclosures and financial statements, so readers can form their own view of what is currently working for the stock and what still needs to be watched.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n